Company intelligence

KTTA

Pasithea Therapeutics Corp. · NASDAQ · Healthcare

Price$0.40-9.05% · −$0.04

Market cap13.53MEquity value

P / E-0.3Trailing ratio

Volume1.53MLatest session

Market data

KTTA price chart

TradingView

Related signals

1 min delayed

Browse public KTTA signals with their source context and measured market impact. Open any signal for its permanent analysis page.

KTTAMay 6, 2025-63.31% since signal

Pasithea Therapeutics Drug Shows Tumor Reduction In Pancreatic Cancer, Strong Early Trial Results

KTTA shares surged 62.7% in premarket trading. Interim data shows strong target engagement from PAS-004 in trials. Preliminary results indicate pERK levels reduced by up to 91%. One patient with pancreatic cancer showed significant tumor reduction. Safety Review Committee recommends advancing trial to Cohort 6.

View signal analysis

Research